Loading company…
Optina Diagnostics develops Optina-4C, a retinal imaging tool for early detection of Alzheimer's disease, from Quebec, Canada.
Founded in 2011 and based in Quebec, Canada, Optina Diagnostics Inc. uses optical techniques adapted from astronomy to examine the inner lining of the eye for amyloid pathology, an early indicator of Alzheimer's disease. In January 2022, it raised USD 2.1 million in venture funding led by the Alzheimer's Drug Discovery Foundation. As of 2024, David Lapointe serves as CEO and president.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in